NERVGEN PHARMA CORP. — All Filings
20 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 6-K | FORM 6-K | 0001104659-26-027740 | Mar 13, 2026 | — |
| 6-K | FORM 6-K | 0001104659-26-015192 | Feb 13, 2026 | — |
| 6-K | FORM 6-K | 0001104659-26-012610 | Feb 10, 2026 | — |
| S-8 | FORM S-8 | 0001104659-26-006289 | Jan 23, 2026 | — |
| 6-K | FORM 6-K | 0001104659-26-002130 | Jan 8, 2026 | — |
| EFFECT | — | 9999999995-26-000094 | Jan 7, 2026 | — |
| CERT | — | 0001354457-26-000019 | Jan 7, 2026 | — |
| 8-A12B | 8-A12B | 0001104659-26-001789 | Jan 7, 2026 | — |
| F-10/A | F-10/A | 0001104659-26-001741 | Jan 7, 2026 | — |
| F-X | FORM F-X | 0001104659-25-122048 | Dec 17, 2025 | — |
| F-10 | F-10 | 0001104659-25-122026 | Dec 17, 2025 | — |
| D | — | 0001567619-21-022000 | Dec 14, 2021 | — |
| D/A | — | 0001567619-21-016280 | Aug 25, 2021 | — |
| D | — | 0001567619-21-015996 | Aug 17, 2021 | — |
| D/A | — | 0001567619-21-011488 | Jun 2, 2021 | — |
| D | — | 0001567619-20-015911 | Aug 25, 2020 | — |
| D | — | 0001567619-20-011570 | Jun 3, 2020 | — |
| D | — | 0001567619-19-022075 | Nov 22, 2019 | — |
| D | — | 0001567619-19-007339 | Mar 21, 2019 | — |
| D | — | 0001534122-18-000024 | Sep 20, 2018 | — |